在患有长期结节切开术的患者中使用塞马格卢提德:一个案例报告强调了临床风险和证据缺口
Gabriela Gaytan1, Andrea Pabon1, Natalie Rosario2
1University of Houston College of Pharmacy, Department of Pharmacy Practice and Translational Research, 4349 Martin Luther King Blvd, Houston, TX.
Journal of the American Pharmacists Association : JAPhA
|March 7, 2026
概括
类似葡萄糖类-1受体激动剂 (GLP-1RA) 可能对胃肠道解剖学变化的患者构成风险,例如胆管切除术. 需要进一步的研究来评估GLP-1RA在这个人群中的安全性.
科学领域:
- 内分泌学 在内分泌学.
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 类似葡萄糖-1受体激动剂 (GLP-1RA) 广泛用于2型糖尿病和体重管理.
- 作为GLP-1RA的塞马格卢提德自2018年美国市场上市以来,已经得到了显著的应用.
- 有限的数据存在GLP-1 RA安全性在患有胃肠道解剖学变化的患者,特别是那些 Ostomies.
研究的目的:
- 为了评估GLP-1RA的安全性和有效性,在患有胃肠道解剖变化的患者中.
- 为了突出与GLP-1 RA在患有骨髓切割的患者中使用相关的潜在风险.
主要方法:
- 一个56岁的男性的案例研究,患有2型糖尿病和乳房结节,使用semaglutide.
- 患者经历了胃肠道运动问题,包括便阻塞,在重新开始服用西马格卢提德后结肠镜检查后.
主要成果:
- 患者最初减轻了体重,并改善了对血糖的控制.
- 在重新开始服用西马格卢提德后,该患者出现了严重的胃肠道问题,导致住院治疗和永久停药.
结论:
- 临床试验和指导方针严重缺乏GLP-1RA在患有结肠静脉切开或显著的胃肠道变化的患者中使用.
- 临床医生应谨慎行事,进行个性化风险益处评估,并在给肠道解剖改变的患者开处方GLP-1RA时与胃肠学合作.
- 进一步的研究是必不可少的,以确定GLP-1RA的安全性,耐受性和药理动力学,在患者的骨髓切除.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...


